Back
LYFE SCIENCES
Project: HERA
NM_000535.7:c.2265C>T
p.Ile755=  ·  PMS2
ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for PMS2 Version 2.0.0 · v2.0.0
Starting
Initialising…
0%
Legacy Engine
Processing…
Classification rationale
1

NM_000535.7:c.2265C>T is a synonymous variant in PMS2 encoding p.(Ile755=) in exon 13 of 15. This variant is present in gnomAD v4.1 at an allele frequency of 0.00574% (92/1,602,058 alleles, including 5 homozygotes) with a grpmax filtering allele frequency of 0.06273%, meeting the MMR VCEP BS1_Strong criterion (>=0.028%).

gnomad_v4 ↗
2

SpliceAI predicts no splicing impact for this synonymous variant (max delta score = 0.00), meeting the MMR VCEP BP4_Supporting criterion for synonymous variants with no predicted splice alteration (delta <=0.1).

spliceai ↗
3

This is a synonymous (silent) variant, meeting the MMR VCEP BP7_Supporting criterion (synonymous variant with no predicted splice impact).

4

The MMR VCEP PM2_Supporting criterion is not met because the gnomAD v4.1 allele frequency (0.00574%) exceeds the VCEP threshold of <0.002% (<1/50,000 alleles). BA1 is not met as the grpmax FAF (0.06273%) is below the 0.28% threshold.

gnomad_v4 ↗
5

PVS1, PS1, PM5, PS4, PM1, PM6, PP2, PP5, BP1, BP2, and BP6 are not applicable per MMR VCEP v2.0.0 specification or because the variant type (synonymous) does not satisfy criterion prerequisites.

6

PS2, PS3, PP1, PP4, BS2, BS3, BS4, and BP5 cannot be assessed due to absence of de novo data, functional studies, cosegregation data, tumor phenotype data, and trans-configuration data in the available evidence.

7

This variant has been reported in ClinVar as Likely benign by 5 clinical laboratories and as Benign by 4 clinical laboratories (ClinVar Variation ID: 220273). Nine of the 11 PMIDs associated with ClinVar submissions are general guidelines/review articles that do not mention this specific variant; the remaining two (PMID:25741868 and PMID:28492532) were reviewed in full text and do not contain variant-specific evidence.

clinvar ↗ PMID:25741868 ↗ PMID:28492532 ↗
8

Applying the MMR VCEP v2.0.0 combining rules: one Benign Strong criterion (BS1) plus two Benign Supporting criteria (BP4, BP7) satisfies both Rule 18 (1 Strong + 1 Supporting => Likely Benign) and Rule 19 (>=2 Supporting => Likely Benign). The combined evidence supports a classification of Likely Benign.

Applied criteria
Met
Not met
Not assessed
N/A
Very strong
Strong
Moderate
Supporting
Pathogenic evidence
PVS
PVS1
PS
PS1
PS2
PS3
PS4
PM
PM1
PM2
PM3
PM4
PM5
PM6
PP
PP1
PP2
PP3
PP4
PP5
Benign evidence
BA
BA1
BS
BS1
BS2
BS3
BS4
BP
BP1
BP2
BP3
BP4
BP5
BP6
BP7
PVS1
Rationale
Select a criterion to inspect its explanation.
Evidence used
Gaps remaining
Rule
Publications
Research and evidence
gnomAD v2.1 evidence
v2.1
gnomAD v4.1 evidence
v4.1
01
Population
gnomAD v2.1This variant is present in gnomAD v2.1 (AF= 8.82301e-05; MAF= 0.00882%, 22/249348 alleles, homozygotes = 2) and has highest observed frequency in the South Asian population (AF= 0.00065647; MAF= 0.06565%, 20/30466 alleles, homozygotes = 2); grpmax FAF= 0.00043432.
gnomAD v4.1This variant is present in gnomAD v4.1 (AF= 5.74261e-05; MAF= 0.00574%, 92/1602058 alleles, homozygotes = 5) and has highest observed frequency in the South Asian population (AF= 0.000773036; MAF= 0.07730%, 70/90552 alleles, homozygotes = 5); grpmax FAF= 0.00062731.
gnomAD CanadaAvailable
ClinVar evidence
02
ClinVar
This variant has been reported in ClinVar as Likely benign (5 clinical laboratories) and as Benign (4 clinical laboratories). (ClinVarID = 220273)
Functional evidence
03
Functional
OncoKB: Unknown Oncogenic Effect
OncoKB identified curated literature and non-variant-specific oncogenicity context for review; listed oncogenicity label: Unknown Oncogenic Effect.
In silico evidence
04
In silico
SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00).
COSMIC evidence
05
COSMIC
This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
Cancer hotspots evidence
06
Cancer hotspots Not found
This variant does not lie in a statistically significant hotspot.